AVNS Logo

Avanos Medical, Inc. (AVNS) Insider Trading Activity

NYSE$12.71
Market Cap
$587.76M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
453 of 878
Rank in Industry
55 of 110

AVNS Insider Trading Activity

AVNS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$106,778
1
100

Related Transactions

Holbrook KerrSVP, Chief Commercial Officer
0
$0
1
$106,778
$-106,778

About Avanos Medical, Inc.

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Insider Activity of Avanos Medical, Inc.

Over the last 12 months, insiders at Avanos Medical, Inc. have bought $0 and sold $106,778 worth of Avanos Medical, Inc. stock.

On average, over the past 5 years, insiders at Avanos Medical, Inc. have bought $84,034 and sold $129,879 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500 shares for transaction amount of $9,925 was made by Shimer Julie Ann (director) on 2024‑03‑11.

List of Insider Buy and Sell Transactions, Avanos Medical, Inc.

2025-03-06SaleHolbrook KerrSVP, Chief Commercial Officer
7,000
0.0153%
$15.25
$106,778
-14.84%
2024-03-14SaleGreiner MichaelSVP - Chief Financial Officer
8,000
0.0169%
$19.12
$152,980
+2.85%
2024-03-11PurchaseShimer Julie Anndirector
500
0.0011%
$19.85
$9,925
-1.01%
2021-09-15PurchaseOLEARY PATRICK Jdirector
5,000
0.0103%
$31.63
$158,143
-2.60%
2020-05-08PurchaseBLACKFORD GARYdirector
10,000
0.0214%
$28.75
$287,500
+43.54%
2019-05-30PurchaseWoody Joseph FralinChief Executive Officer
7,000
0.0074%
$19.98
$139,825
-15.72%
2018-11-28PurchaseWoody Joseph FralinChief Executive Officer
7,000
0.0141%
$43.35
$303,450
-6.93%
2018-11-27PurchaseVoskuil Steven ESVP, Chief Financial Officer
4,000
0.0042%
$21.87
$87,470
-2.90%
2018-11-19PurchaseWesley John WSVP, General Counsel
2,000
0.0043%
$47.48
$94,960
-9.68%
2015-09-04PurchaseABERNATHY ROBERT EChairman and CEO
20,000
0.0431%
$31.06
$621,200
+0.10%
2015-09-01PurchaseVoskuil Steven ESVP, Chief Financial Officer
2,000
0.0043%
$30.00
$60,000
+3.03%
Total: 11
*Gray background shows transactions not older than one year

Insider Historical Profitability

0.87%
Holbrook KerrSVP, Chief Commercial Officer
82047
0.1774%
$1.04M01
Greiner MichaelSVP - Chief Financial Officer
151495
0.3276%
$1.93M01
ABERNATHY ROBERT EChairman and CEO
80043
0.1731%
$1.02M10
+0.1%
Shimer Julie Anndirector
50090
0.1083%
$636,643.9010
<0.0001%
BLACKFORD GARYdirector
34845
0.0754%
$442,879.9510
+43.54%
OLEARY PATRICK Jdirector
33900
0.0733%
$430,869.0010
<0.0001%
Woody Joseph FralinChief Executive Officer
28556
0.0618%
$362,946.7620
<0.0001%
Voskuil Steven ESVP, Chief Financial Officer
22238
0.0481%
$282,644.9820
+0.07%
Wesley John WSVP, General Counsel
7502
0.0162%
$95,350.4210
<0.0001%
*Gray background shows insiders who have made transactions during last year

AVNS Institutional Investors: Active Positions

Increased Positions113+36.69%4M+9.68%
Decreased Positions116-37.66%5M-12.91%
New Positions45New2MNew
Sold Out Positions46Sold Out2MSold Out
Total Postitions305-0.97%41M-3.23%

AVNS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$84,764.0014.99%6.9M-254,859-3.56%2025-03-31
Vanguard Group Inc$65,626.0011.61%5.34M+19,476+0.37%2024-12-31
T. Rowe Price Investment Management, Inc.$37,009.006.55%3.01M+644,267+27.22%2024-12-31
Rgm Capital, Llc$36,704.006.49%2.99M-184,936-5.83%2024-12-31
Dimensional Fund Advisors Lp$31,688.005.61%2.58M-11,668-0.45%2024-12-31
State Street Corp$24,090.004.26%1.96M+138,239+7.59%2024-12-31
Brown Advisory Inc$23,734.004.2%1.93M+26,069+1.37%2025-03-31
William Blair Investment Management, Llc$17,282.003.06%1.41M+28,608+2.08%2024-12-31
Paradice Investment Management Llc$15,893.002.81%1.29M+30,949+2.45%2024-12-31
Westwood Holdings Group Inc$15,492.002.74%1.26M-730,486-36.69%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.